Omega Pharma NV - Strategy, SWOT and Corporate Finance Report

August 2018 | 29 pages | ID: OE9583FCEEBEN
MarketLine

Abstracts

Omega Pharma NV - Strategy, SWOT and Corporate Finance Report

SUMMARY

Omega Pharma NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

KEY HIGHLIGHTS

Omega Pharma NV (Omega or 'the company'), is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.

SCOPE

• Detailed information on Omega Pharma NV required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis
• An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments
• Intelligence on Omega Pharma NV's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Omega Pharma NV, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

REASONS TO BUY

• Gain understanding of Omega Pharma NV and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Omega Pharma NV as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Omega Pharma NV's business structure, strategy and prospects.

Contents

Company Snapshot
Table of Contents
Omega Pharma NV: Company Overview
Omega Pharma NV: Overview and Key Facts
Omega Pharma NV: Overview
Omega Pharma NV: Key Facts
Omega Pharma NV: Key Employees
Omega Pharma NV: Major Products and Services
Omega Pharma NV: Company History
Omega Pharma NV: Management Statement
Omega Pharma NV: Locations and Subsidiaries
Omega Pharma NV: Key Competitors
Omega Pharma NV: Company Analysis
Omega Pharma NV: Business Description
Omega Pharma NV: SWOT Analysis
Omega Pharma NV: SWOT Overview
Omega Pharma NV: Strengths
Omega Pharma NV: Weaknesses
Omega Pharma NV: Opportunities
Omega Pharma NV: Threats
Omega Pharma NV: Corporate Financial Deals Activity
Omega Pharma NV: Financial Deals Overview
Omega Pharma NV: Targets and Partners
Omega Pharma NV: Top Deals 2014 - 2018YTD*
Omega Pharma NV: Partnership
Omega Pharma NV: Private Equity and Ownership
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Omega Pharma NV: Key Facts
Table 2: Omega Pharma NV: Key Employees
Table 3: Omega Pharma NV: Locations and Subsidiaries
Table 4: Omega Pharma NV: Key Competitors
Table 5: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM)
Table 6: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Table 7: Omega Pharma NV: Targets and Partners
Table 8: Omega Pharma NV: Top Deals 2014 - 2018YTD
Table 9: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD2018)
Table 10: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD2018)
Table 11: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD2018)
Table 12: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD2018)

List Of Figures

LIST OF FIGURES

Figure 1: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Figure 3: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD2018)
Figure 4: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD2018)
Figure 5: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD2018)
Figure 6: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD2018)